Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 27% ± 13% | |
glutamatergic neuron | 5 studies | 43% ± 21% | |
interneuron | 4 studies | 34% ± 21% | |
cardiac muscle cell | 4 studies | 23% ± 9% | |
GABAergic neuron | 4 studies | 43% ± 15% | |
oligodendrocyte | 4 studies | 22% ± 4% | |
neuron | 3 studies | 23% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 22% ± 0% | |
epithelial cell | 3 studies | 25% ± 7% | |
ciliated cell | 3 studies | 17% ± 1% | |
lymphocyte | 3 studies | 17% ± 1% | |
transit amplifying cell | 3 studies | 31% ± 15% | |
astrocyte | 3 studies | 31% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3243.78 | 1445 / 1445 | 100% | 18.26 | 183 / 183 |
breast | 100% | 2900.36 | 459 / 459 | 100% | 16.54 | 1117 / 1118 |
uterus | 100% | 3265.96 | 170 / 170 | 100% | 16.53 | 458 / 459 |
thymus | 100% | 3034.24 | 653 / 653 | 99% | 12.91 | 601 / 605 |
bladder | 100% | 3332.10 | 21 / 21 | 99% | 12.38 | 500 / 504 |
intestine | 100% | 3264.77 | 966 / 966 | 99% | 10.81 | 522 / 527 |
skin | 100% | 3753.34 | 1807 / 1809 | 99% | 12.38 | 468 / 472 |
prostate | 100% | 3032.99 | 244 / 245 | 99% | 10.48 | 496 / 502 |
brain | 98% | 3932.65 | 2592 / 2642 | 100% | 17.01 | 702 / 705 |
stomach | 100% | 2255.03 | 358 / 359 | 98% | 11.80 | 279 / 286 |
lung | 99% | 2780.57 | 575 / 578 | 97% | 11.22 | 1116 / 1155 |
adrenal gland | 100% | 3066.06 | 258 / 258 | 95% | 11.32 | 219 / 230 |
ovary | 100% | 3251.64 | 180 / 180 | 93% | 11.07 | 401 / 430 |
kidney | 100% | 1873.04 | 89 / 89 | 91% | 7.02 | 819 / 901 |
pancreas | 87% | 1179.29 | 285 / 328 | 98% | 9.94 | 174 / 178 |
liver | 96% | 1496.72 | 217 / 226 | 83% | 5.86 | 337 / 406 |
adipose | 100% | 2842.43 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.65 | 29 / 29 |
muscle | 100% | 49008.30 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3260.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.92 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.17 | 1 / 1 |
blood vessel | 100% | 3117.89 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 4049.38 | 828 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 7.81 | 76 / 80 |
peripheral blood | 73% | 2140.22 | 676 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0060271 | Biological process | cilium assembly |
GO_0090316 | Biological process | positive regulation of intracellular protein transport |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_0007052 | Biological process | mitotic spindle organization |
GO_0005814 | Cellular component | centriole |
GO_0005813 | Cellular component | centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0005874 | Cellular component | microtubule |
GO_0034451 | Cellular component | centriolar satellite |
GO_0016020 | Cellular component | membrane |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
GO_0060090 | Molecular function | molecular adaptor activity |
Gene name | PCNT |
Protein name | Pericentrin (Kendrin) (Pericentrin-B) Pericentrin PCNT protein |
Synonyms | PCNT2 KIAA0402 |
Description | FUNCTION: Integral component of the filamentous matrix of the centrosome involved in the initial establishment of organized microtubule arrays in both mitosis and meiosis. Plays a role, together with DISC1, in the microtubule network formation. Is an integral component of the pericentriolar material (PCM). May play an important role in preventing premature centrosome splitting during interphase by inhibiting NEK2 kinase activity at the centrosome. . |
Accessions | ENST00000490468.5 ENST00000359568.10 [O95613-1] A0A8Q3SHZ3 H7C2A3 A0A8Q3SHV6 A0A8Q3SI04 ENST00000695530.1 ENST00000703224.1 ENST00000466474.6 O95613 ENST00000695526.1 A0A8Q3SHY5 ENST00000695528.1 A0A8V8TQ91 A0A8V8TQT6 ENST00000695558.1 Q8IWJ7 ENST00000480896.5 [O95613-2] ENST00000418394.2 A0A8Q3SHZ8 |